F. Espersen
Impact in
- Clinical Biochemistry top 0.5%
- Bacterial Identification and Susceptibility Testing
- Infectious Diseases top 0.5%
- Antimicrobial Resistance in Staphylococcus
Papers in
-
- Antimicrobial Resistance in Staphylococcus 77
- Epidemiology 58
- Infective Endocarditis Diagnosis and Management 26
- Pneumonia and Respiratory Infections 16
- Co-authors
- Jens Kjølseth Møller (27 shared papers)Niels Høiby (35 shared papers)Vibeke Thamdrup Rosdahl (32 shared papers)Peter Skinhøj (19 shared papers)Niels Frimodt‐Møller (15 shared papers)Allan G. Jensen (7 shared papers)Inge Clemmensen (9 shared papers)Susanne S. Pedersen (9 shared papers)
- Journals
- Apmis (29 papers)Infection and Immunity (11 papers)Journal of Clinical Microbiology (10 papers)Antimicrobial Agents and Chemotherapy (9 papers)Inflammation Research (6 papers)
- Partner nations
- DenmarkUnited StatesSweden
In The Last Decade
F. Espersen
185 papers receiving 5.3k citations
Peers
Comparison fields: 5 of 136
- Clinical Biochemistry 731
- Infectious Diseases 1.8k
- Molecular Medicine 468
- Endocrinology 479
- Microbiology 504
Countries citing papers authored by F. Espersen
This map shows the geographic impact of F. Espersen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Espersen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Espersen more than expected).
Fields of papers citing papers by F. Espersen
This network shows the impact of papers produced by F. Espersen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Espersen. The network helps show where F. Espersen may publish in the future.
Co-authors
The 25 scholars most cited alongside F. Espersen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 189 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 224 | |
| 2 | 1992 | 197 | |
| 3 | 1995 | 175 | |
| 4 | 1997 | 158 | |
| 5 | 1990 | 153 | |
| 6 | 2001 | 139 | |
| 7 | 2006 | 135 | |
| 8 | 1999 | 133 | |
| 9 | 1996 | 128 | |
| 10 | 1994 | 127 | |
| 11 | 1998 | 124 | |
| 12 | 1999 | 124 | |
| 13 | 1997 | 120 | |
| 14 | 1982 | 108 | |
| 15 | 2004 | 100 | |
| 16 | Staphylococcus aureus endocarditis. A review of 119 cases. | 1986 | 85 |
| 17 | 2000 | 84 | |
| 18 | 1991 | 78 | |
| 19 | 1997 | 67 | |
| 20 | 1987 | 65 |
About F. Espersen
F. Espersen is a scholar working on Infectious Diseases, Epidemiology, Clinical Biochemistry, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 189 papers that have together received 5.7k indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (77 papers), Bacterial Identification and Susceptibility Testing (37 papers), Infective Endocarditis Diagnosis and Management (26 papers), Streptococcal Infections and Treatments (21 papers), Cystic Fibrosis Research Advances (17 papers), Bacterial biofilms and quorum sensing (16 papers), Pneumonia and Respiratory Infections (16 papers) and Antibiotics Pharmacokinetics and Efficacy (15 papers). The work is most often cited by research in Clinical Biochemistry (731 citations), Infectious Diseases (1.8k citations), Molecular Medicine (468 citations), Endocrinology (479 citations) and Microbiology (504 citations). F. Espersen has collaborated with scholars based in Denmark, United States and Sweden. Frequent co-authors include Jens Kjølseth Møller, Niels Høiby, Vibeke Thamdrup Rosdahl, Peter Skinhøj, Niels Frimodt‐Møller, Allan G. Jensen, Inge Clemmensen, Susanne S. Pedersen, Jenny Dahl Knudsen and Christian Koch. Their work appears in journals such as Apmis, Infection and Immunity, Journal of Clinical Microbiology, Antimicrobial Agents and Chemotherapy and Inflammation Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.